Künstliche Luft Zur Medizinischen Anwendung Air Products (Oxygen)

Inhaled oxygen diffuses across the alveolar membrane into the bloodstream, raising the partial pressure of oxygen in the pulmonary capillaries. This increases hemoglobin saturation, elevates arterial oxygen tension, and enhances delivery of oxygen to tissues, supporting cellular metabolism and organ function.

The prescribed dose of oxygen is individualized. A healthcare professional determines the appropriate flow rate (e.g., liters per minute) and duration based on the patient’s oxygen saturation, underlying condition, and clinical response. No fixed regimen is provided in the product information.

Limited specific data are available for use in pregnancy or lactation. Oxygen is generally considered compatible when medically indicated, but the prescriber should evaluate the risk‑benefit profile for each individual patient and monitor both mother and infant as appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Künstliche Luft Zur Medizinischen Anwendung Air Products provides 100 % medical‑grade oxygen, which offers higher purity than compressed air or ambient air mixtures. Compared with lower‑purity oxygen sources, it delivers more reliable and consistent arterial oxygenation, making it preferable for critical care, anesthesia, and severe hypoxemia.

Store the oxygen cylinders upright in a cool, dry, well‑ventilated area away from heat sources and direct sunlight. Keep the temperature below 25 °C, protect from physical damage, and ensure that cylinders are secured to prevent tipping. Follow all local regulations for medical gas storage.

The gas is supplied in high‑pressure cylinders equipped with regulators. It is delivered to the patient via approved devices such as nasal cannulas, simple or non‑rebreather masks, or high‑flow systems, depending on the clinical need and prescribed flow rate.

Serious risks include oxygen toxicity (pulmonary edema, seizures), fire or explosion hazards when exposed to ignition sources, and CO₂ retention in patients with severe COPD who receive high flow rates. Continuous monitoring and adherence to safety protocols are essential to mitigate these risks.

Patients with uncontrolled fire hazards, those who are actively smoking, or individuals with certain severe COPD phenotypes at high risk for CO₂ retention should avoid unsupervised use. Additionally, anyone with a known hypersensitivity to the cylinder materials or who lacks appropriate medical supervision should not use the product.